The brief negative symptom scale: psychometric properties. - sprookjes - yvandenbroek - TriplyDB

The brief negative symptom scale: psychometric properties.

The brief negative symptom scale: psychometric properties.

http://www.wikidata.org/entity/Q33608454

about

The translational study of apathy-an ecological approach Motivational Deficits in Schizophrenia and the Representation of Expected Value Anhedonia: a concept analysis The current conceptualization of negative symptoms in schizophrenia Vocal expression in schizophrenia: Less than meets the ear.Speech deficits in serious mental illness: a cognitive resource issue?What do we really know about blunted vocal affect and alogia? A meta-analysis of objective assessments.Computerized facial analysis for understanding constricted/blunted affect: initial feasibility, reliability, and validity data Emotion regulation abnormalities in schizophrenia: cognitive change strategies fail to decrease the neural response to unpleasant stimuli Neurobiological background of negative symptoms.A study of trait anhedonia in non-clinical Chinese samples: evidence from the Chapman Scales for Physical and Social Anhedonia.Natural language processing to extract symptoms of severe mental illness from clinical text: the Clinical Record Interactive Search Comprehensive Data Extraction (CRIS-CODE) project.Pathways from Trauma to Psychotic Experiences: A Theoretically Informed Model of Posttraumatic Stress in Psychosis.Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment Methodological issues in negative symptom trials Reduced susceptibility to confirmation bias in schizophrenia Negative symptoms in schizophrenia.Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions.Working memory contributions to reinforcement learning impairments in schizophrenia Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia.Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.Distress intolerance and clinical functioning in persons with schizophrenia Cognitive effort avoidance and detection in people with schizophrenia.The role of low cognitive effort and negative symptoms in neuropsychological impairment in schizophrenia Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort.Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.Predictors of neuropsychological effort test performance in schizophrenia Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli Instruments measuring blunted affect in schizophrenia: a systematic review A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.Confirmatory Factor Analysis and Differential Relationships of the Two Subdomains of Negative Symptoms in Chronically Ill Psychotic Patients.Probing the Dynamic Updating of Value in Schizophrenia Using a Sensory-Specific Satiety Paradigm.Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method.The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.Cognition-emotion interactions are modulated by working memory capacity in individuals with schizophrenia.Attacking Heterogeneity in Schizophrenia by Deriving Clinical Subgroups From Widely Available Symptom Data.Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.Factor structure of the Brief Negative Symptom Scale.Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task.

P2860

Q26781597-BA1CB982-E0FC-4F14-83EA-A8D85511CF03 Q26786992-5C24F312-5D52-4E8D-929C-CD294CDC033D Q26863341-48FEE382-1594-4CFB-B038-882A57F963C6 Q30364829-D6D41C01-29FF-472B-9D04-4B0E191E6CF2 Q30378034-0A911B13-A282-4869-927D-DE61292A5757 Q30397612-D223E997-7D5F-467E-B7AA-99740A9C086A Q30400036-A6EE841E-A97E-49DD-8202-961D8E0D90F2 Q30433935-D409A286-ED02-4C52-B51B-DB9256689AFE Q30540763-2BDB7DB0-689C-4F77-AF70-DE73631E575B Q30913824-45ADDEF7-48CE-430E-9BC9-F245A8F018AD Q31056281-203730E6-66CC-45B1-8F5B-94A5FDCD3A81 Q31155106-8091EB87-CEB4-4EAF-BF03-11D7B87542EC Q33716543-F996E357-8AD8-4DC8-844C-8583909799EC Q33724110-13D823D1-69E6-4E0A-A166-4A6A99C6FFA2 Q33804836-5710862A-E7F3-499C-B083-0FF8F503579B Q33818756-F76FB54A-076C-410F-BB1E-69EDB02B6BB6 Q33820512-DD3BD90D-74DE-4918-A799-B35B2E8CF7DC Q33882729-44BABC66-C098-4AC5-855B-80C2F067C6E1 Q34303262-9D91A32F-71F8-442E-903D-9081AF1C7388 Q34574292-F0AD6609-3CFE-45A2-ACF7-CD4265CE6AD3 Q34604423-7C49FEE2-946B-4B40-8CFF-A961F3D6DF89 Q34615831-D06AB1C4-DCD0-4A21-93D6-98487B7BDDF0 Q34772481-C05CFD16-FB3C-4C93-9C37-8D51AA8483B0 Q34861684-C8AF7672-75CB-4534-A2B3-0AF17167276D Q35096548-5D8FDD7E-C186-4643-890B-1DB82E1FE914 Q35116515-81A5820C-2592-4A6C-8277-C77C3843458B Q35118062-93D70B0B-3906-42D7-8B31-5448CCEC0C5B Q35118483-1E511483-52A4-4408-AD3E-C05C8C01EA08 Q35598024-8EDC1512-2AD1-4136-B994-7188A370A335 Q35649715-D717EB56-7808-43A5-A92A-B10C89530E5C Q35794290-D4A51F48-25A8-442E-84D9-3A3F7F9FA819 Q35928639-4C4413EE-C642-44B6-98E4-B8982A791E3E Q35950820-E1151811-A121-4E8D-B693-A4CAE14ECFEA Q36081015-0B3E4A14-EBAC-4673-A2AB-0A12E7660A26 Q36201440-76F04FBC-8B29-4B35-8E64-1773618B6648 Q36303044-D12910B2-B765-463D-918A-C8C24C8EDE46 Q36332243-999DE8A0-7676-42E0-B18E-C8C3F5C6C528 Q36412864-105993CC-3594-403B-8C97-22EAB19A8648 Q36412889-7057A9B5-47F8-4C8B-A7ED-10F360F4E721 Q36447607-49A725B1-9451-4CBC-8380-D03E66442990

P2860

The brief negative symptom scale: psychometric properties.

http://www.wikidata.org/entity/Q33608454

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The brief negative symptom scale: psychometric properties.

@ast

The brief negative symptom scale: psychometric properties.

@en

type

label

The brief negative symptom scale: psychometric properties.

@ast

The brief negative symptom scale: psychometric properties.

@en

prefLabel

The brief negative symptom scale: psychometric properties.

@ast

The brief negative symptom scale: psychometric properties.

@en

P1433

Q33608454-BACA271F-7D8D-4881-ABF5-7AB812211E0D

P1476

Q33608454-087B7A24-61FE-4BA9-90B5-D38B9A636D4C

P2093

Q33608454-31977A23-0E28-44A9-B0B5-84E1B6429F1D

Q33608454-34D4795E-78D1-4A49-967F-F1457E22334D

Q33608454-6D5DB532-A4D1-43FE-97A3-7F7A6B41B651

Q33608454-A4BC3ABE-E0E7-4A05-A795-A03A9C9401D4

Q33608454-A7F6B1E8-34FE-4A4A-BE0E-008466D4FDE1

Q33608454-E7F34AEC-633C-4810-BC1D-44CA6B4B97D3

P2860

Q33608454-0117A581-A6CD-490F-8226-ABC1B2B980D9

Q33608454-113949DB-968B-44A0-9936-E64DF47ED789

Q33608454-330C8842-CB33-439C-87ED-2129F0780116

Q33608454-33E31262-7A3C-4509-BF5E-D5855DB1227D

Q33608454-4B75CC9D-6530-44C7-A1DA-1F0EC2711297

Q33608454-4C287FF5-D7EC-4D10-8E64-D78A16D4B173

Q33608454-640CF501-263F-415E-9333-AF0BE0F4463A

Q33608454-65839B28-535D-4EDD-8E17-52BE2CF94402

Q33608454-7AD03D5B-917C-4D80-8F1C-8F89152C78EC

Q33608454-90BD36ED-AC24-428A-8809-00ECAF2FD39C

P304

Q33608454-CA01EC38-9BC0-4063-BE8E-2ACC5BE2083F

P31

Q33608454-E3D80AB3-B64C-43B5-B255-5C65CF5E4426

P356

Q33608454-EC6C451B-370D-4D92-81C7-160560D46B0B

P407

Q33608454-46212647-4CA2-45A2-A724-04A73C6EDEE8

P433

Q33608454-9D59A8D9-E987-455E-806B-83537F15C06A

P478

Q33608454-5BC2B02E-3F32-4C9F-85BE-A5F876D15561

P50

Q33608454-b0c86666-428e-d273-080c-88be88535b2f

P577

Q33608454-FD01B62D-B361-492A-B5EC-A2375A37D91B

P5875

Q33608454-C8C3716A-4B46-4F42-9FD5-58DFEF88302A

P698

Q33608454-22F268DB-F20B-4605-BAAE-B5BB2B02927A

P932

Q33608454-5F70889D-A5AA-4BC6-85B0-F1F71F4C4F95

P356

P1433

Schizophrenia Bulletin

P1476

The brief negative symptom scale: psychometric properties.

@en

P2093

Angel Cienfuegos

http://www.w3.org/2001/XMLSchema#string

Bernard A Fischer

http://www.w3.org/2001/XMLSchema#string

David G Daniel

http://www.w3.org/2001/XMLSchema#string

Gregory P Strauss

http://www.w3.org/2001/XMLSchema#string

Linh Nguyen

http://www.w3.org/2001/XMLSchema#string

Stephen R Marder

http://www.w3.org/2001/XMLSchema#string

P2860

The positive and negative syndrome scale (PANSS) for schizophrenia

Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia.

A separate disease within the syndrome of schizophrenia.

The two-syndrome concept: origins and current status.

Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure

The structure of negative symptoms within schizophrenia: implications for assessment.

The NIMH-MATRICS consensus statement on negative symptoms.

Deficit schizophrenia: association with serum antibodies to cytomegalovirus.

Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim.

Differences in glucose tolerance between deficit and nondeficit schizophrenia

P304

300-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SCHBUL/SBQ059

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Brian Kirkpatrick

P577

2010-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44683250

http://www.w3.org/2001/XMLSchema#string

P698

20558531

http://www.w3.org/2001/XMLSchema#string

P932

3044634

http://www.w3.org/2001/XMLSchema#string